ENTERTAINMENT
May 14, 2012 | By Ben Fritz and Steven Zeitchik, Los Angeles Times
Often film sequels are slam dunks at the box office, a seamless continuation from where a previous hit left off. But as the new installment of the 15-year-old franchise "Men in Black" proves, getting to the big screen isn't always a cakewalk. One of the most troubled productions in recent Hollywood memory, Sony Pictures' latest movie in the Will Smith-Tommy Lee Jones sci-fi-comedy franchise encountered multiple script rewrites, a discontented star and a three-month production shutdown as writers and studio executives scrambled to fix a project that nearly fell apart . By the time it was over, the studio had run up a tab of nearly $250 million - making "Men in Black 3" one of the most expensive releases of the summer.
BUSINESS
October 30, 2011 | Ken Bensinger, Los Angeles Times
First of three parts Tiffany Lee wanted a car. She was weary of the two-hour bus ride to her job at a UCLA Health System clinic. She hated having to ask friends to drive her 7-year-old son to his asthma treatments. But as a single mother with three children, bad credit and a $27,000-a-year salary, she couldn't find a bank or dealership willing to give her a loan. Then a friend steered her to Repossess Auto Sales in Hawthorne. Another buyer might have balked at the deal she was offered.
BUSINESS
May 9, 2012 | By E. Scott Reckard, Los Angeles Times
A newly streamlined government plan to reward homeowners who diligently pay their underwater mortgages is proving a bonanza for banks, which by one estimate may pocket $12 billion in extra revenue by refinancing loans. The revisions to the Obama administration's 3-year-old Home Affordable Refinance Program have yielded mixed results for homeowners, analysts and mortgage professionals say. Some responsible homeowners are indeed getting lower-interest loans despite owing far more than their homes are worth.
HEALTH
March 16, 2009 | Elena Conis
Teas from across the globe are becoming more and more popular in the U.S. One relative newcomer, yerba mate, is attracting fans for its allegedly jitter-free caffeine boost and high antioxidant content. Lab research suggests some potential health benefits from drinking yerba mate, but studies of lifelong yerba mate drinkers in the tea's native South America suggest the brew increases the risk of some cancers -- a fact most marketing campaigns omit.
CALIFORNIA | LOCAL
July 27, 2011 | By Ari Bloomekatz, Abby Sewell and Kate Mather, Los Angeles Times
Bob Brickman spent months fighting a ticket he got last fall from a red-light traffic camera at Wilshire and Sepulveda boulevards in West Los Angeles. The 61-year-old from Playa Vista eventually decided to give up the fight and fork over the $476 fine. Now he's regretting paying every penny. City officials this week spotlighted a surprising revelation involving red-light camera tickets: Authorities cannot force violators who simply don't respond to pay them. For a variety of reasons, including the way the law was written, Los Angeles officials say the fines for ticketed motorists are essentially "voluntary" and there are virtually no tangible consequences for those who refuse to pay. The disclosure comes as the city is considering whether to drop the controversial photo enforcement program, with the City Council scheduled to vote on the matter Wednesday.
HEALTH
January 16, 2012 | By Lisa Zamosky, Special to the Los Angeles Times
Lipitor is the most prescribed name-brand drug in America - nearly 3.5 million people take it every day to control their cholesterol. Since the statin entered the market in 1997, it's earned New York-based pharmaceutical giant Pfizer Inc. $81 billion, making it the best-selling prescription drug of all time, according to IMS Health, a Danbury, Conn.-based healthcare information company. So when Lipitor's patent protection came to an end Nov. 30 and a generic alternative became available, an awful lot of patients had a decision to make: Should they stick with the drug they knew or switch to something less expensive?